ArticleCureus2022

Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report.

Yoshiro Kai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.